- Home
- FVRR vs ORIC Comparison
FVRR vs ORIC Comparison
Compare FVRR & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FVRR
- ORIC
- Stock Information
- Founded
- FVRR 2010
- ORIC 2014
- Country
- FVRR Israel
- ORIC United States
- Employees
- FVRR N/A
- ORIC N/A
- Industry
- FVRR Business Services
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FVRR Consumer Discretionary
- ORIC Health Care
- Exchange
- FVRR Nasdaq
- ORIC Nasdaq
- Market Cap
- FVRR 933.7M
- ORIC 1.1B
- IPO Year
- FVRR 2019
- ORIC 2020
- Fundamental
- Price
- FVRR $23.44
- ORIC $14.33
- Analyst Decision
- FVRR Buy
- ORIC Strong Buy
- Analyst Count
- FVRR 11
- ORIC 8
- Target Price
- FVRR $32.91
- ORIC $16.57
- AVG Volume (30 Days)
- FVRR 822.3K
- ORIC 1.6M
- Earning Date
- FVRR 10-29-2025
- ORIC 11-11-2025
- Dividend Yield
- FVRR N/A
- ORIC N/A
- EPS Growth
- FVRR 70.84
- ORIC N/A
- EPS
- FVRR 0.50
- ORIC N/A
- Revenue
- FVRR $419,126,000.00
- ORIC N/A
- Revenue This Year
- FVRR $12.80
- ORIC N/A
- Revenue Next Year
- FVRR $6.58
- ORIC N/A
- P/E Ratio
- FVRR $47.39
- ORIC N/A
- Revenue Growth
- FVRR 12.60
- ORIC N/A
- 52 Week Low
- FVRR $20.83
- ORIC $3.90
- 52 Week High
- FVRR $36.11
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- FVRR 45.36
- ORIC 74.12
- Support Level
- FVRR $23.25
- ORIC $13.85
- Resistance Level
- FVRR $24.39
- ORIC $14.93
- Average True Range (ATR)
- FVRR 0.82
- ORIC 0.81
- MACD
- FVRR -0.15
- ORIC 0.37
- Stochastic Oscillator
- FVRR 8.43
- ORIC 89.45
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.